natgillin/translations-raw huggingface dataset:
The most common side effects with Gilenya (seen in more than 1 patient in 10) are flu infections, sinusitis (inflammation of the sinuses), headache, cough, diarrhoea, back pain and raised liver enzyme levels.
Najčešće nuspojave lijeka Gilenya (zabilježene u više od 1 na 10 bolesnika) su infekcije gripe, sinusitis (upala sinusa), glavobolja, kašalj, proljev, bol u leđima i povišene razine jetrenih enzima.
The most common side effects with Humira (seen in more than 1 patient in 10) were respiratory tract infections (infections of the lungs and airways), leucopenia (low white blood cell counts), anaemia (low red blood cell counts), increased blood levels of lipids (fats), headache, abdominal pain (stomach ache), nausea (feeling sick) and vomiting, rash, musculoskeletal pain (pain in the muscles and bones), injection-site reactions (including redness) and increased levels of liver enzymes.
Najčešće nuspojave lijeka Humira (uočene u više od 1 na 10 bolesnika) bile su infekcije dišnog sustava (infekcije pluća i dišnih putova), leukopenija (nizak broj bijelih krvnih stanica), anemija (nizak broj crvenih krvnih stanica), povišene razine lipida (masti) u krvi, glavobolja, bol u trbuhu (trbobolja), mučnina (osjećaj slabosti) i povraćanje, osip, bol u mišićima i kostima, reakcije na mjestu injekcije (uključujući crvenilo) i povišene razine jetrenih enzima.
The most common side effects with Ilaris are infections, generally mild to moderate, of the upper respiratory tract (colds).
Najčešće nuspojave s lijekom Ilaris su upale, općenito blage do umjerene, gornjeg respiratornog trakta (prehlade).
The most common side effects with Imbruvica (which may affect more than 1 in 5 people) are diarrhoea, neutropenia (low levels of neutrophils, a type of white blood cell), musculoskeletal pain (pain in muscles and bones), haemorrhage (bleeding), bruising, rash, nausea (feeling sick) and fever.
Najčešće nuspojave pri primjeni lijeka Imbruvica (zabilježene u više od 1 na 5 osoba) su proljev, neutropenija (niske razine neutrofila, tipa bijelih krvnih stanica), mišićnokoštana bolest (bol u mišićima i kostima), hemoragija (krvarenje), modrice, osip, mučnina (slabost) i vrućica.
The most common side effects with Imnovid (which affect more than 1 in 10 patients), some of which were serious, include anaemia (low red-blood-cell counts), neutropenia (low white-blood-cell count), fatigue (tiredness), thrombocytopenia (low platelet counts), pyrexia (fever), peripheral oedema (swelling, especially of the ankles and feet), peripheral neuropathy (nerve damage causing tingling, pain and numbness in the hands and feet) and pneumonia (infection of the lungs).
Najčešće nuspojave kod Imnovida (koje zahvaćaju više od 1 na 10 bolesnika) od kojih su neke bile ozbiljne uključuju anemiju (nizak broj crvenih krvnih stanica), neutropeniju (nizak broj bijelih krvnih stanica), umor (zamorenost), trombocitopeniju (nizak broj trombocita), pireksiju (vrućica), periferni edem (oticanje, posebice gležnjeva i stopala), perifernu neuropatiju (oštećenje živca koje uzrokuje žarenje, bol i obamrlost šaka i stopala) te pneumoniju (infekcija pluća).
The most common side effects with Imvanex (which may affect more than 1 in 10 people) are headache, nausea, myalgia (muscle pain), tiredness and injection site reactions (pain, redness, swelling, hardening and itching).
Najčešće nuspojave cjepiva Imvanex (mogu se javiti u više od jedne na 10 osoba) su glavobolja, mučnina, mijalgija (bol u mišićima), umor i reakcije na mjestu primjene (bol, crvenilo, oticanje, otvrdnuće i svrbež).
The most common side effects with Incruse (seen in between 1 and 10 patients in 100) are headache, nasopharyngitis (inflammation of the nose and throat), upper respiratory tract infection (cold), sinusitis, cough, urinary tract infection, and tachycardia (increased heart rate).
Najčešće nuspojave kod lijeka Incruse (koje se mogu javiti u1 do 10 na 100 osoba) su glavobolja, nazofaringitis (upala nosa i grla), infekcija gornjeg respiratornog trakta (prehlada), sinusitis, kašalj, infekcija urinarnog trakta i tahikardija (ubrzanje srčanog ritma).
The most common side effects with Instanyl (seen in between 1 and 10 patients in 100) are somnolence (sleepiness), dizziness, headache, vertigo (a spinning sensation), flushing (reddening), hot flushes, throat irritation, nausea (feeling sick), vomiting and hyperhidrosis (excessive sweating).
Najčešće nuspojave od lijeka Instanyl (kod između 1 i 10 na 100 osoba) su somnolencija (pospanost), vrtoglavica, glavobolja, vertigo (osjećaj vrtnje), rumenilo (crvenilo), napadaji vrućine, nadraženost grla, mučnina (osjećaj slabosti), povraćanje i hiperhidroza (prekomjerno znojenje).
The most common side effects with Isentress (seen in between 1 and 10 patients in 100) are abnormal dreams, nightmares, insomnia (difficulty sleeping), depression, abnormal behaviour, dizziness, headache, psychomotor hyperactivity (restlessness), vertigo (a spinning sensation), decreased appetite, abdominal distension (swollen tummy), abdominal pain (stomach ache), diarrhoea, flatulence (gas), nausea (feeling sick), vomiting, dyspepsia (indigestion), rash, asthenia (weakness), fatigue (tiredness), pyrexia (fever), atypical lymphocytes (abnormal white blood cells), and increased blood levels of some enzymes (alanine aminotransferase, aspartate aminotransferase, lipase and pancreatic amylase) and triglycerides (a type of fat).
Najčešće nuspojave lijeka Isentress (zabilježene kod 1 do 10 osoba na 100) su abnormalni snovi, noćne more, insomnija (poteškoće sa spavanjem), depresija, abnormalno ponašanje, vrtoglavica, glavobolja, psihomotorna hiperaktivnost (nemir), vertigo (osjećaj vrtoglavice), smanjeni apetit, abdominalna distenzija (natečen trbuh), abdominalna bol (bol u želucu), proljev, nadutost (plinovi), mučnina (osjećaj slabodti), povraćanje, dispepsija (indigestija), osip, astenija (slabost), iscrpljenost (umor), pireksija (groznica), atipični limfociti (abnormalne bijele krvne stanice) i povećane koncentracije određenih enzima u krvi (alanin aminotransferaza, aspartat aminotransferaza, lipaza i pankreatična amilaza) i trigliceridi (tip masti).
The most common side effects with Ixiaro in adults (seen in more than 1 patient in 10) are headache, myalgia (muscle pain), pain and tenderness at the injection site and tiredness.
Najčešće nuspojave povezane s lijekom Ixiaro u odraslih osoba (uočene kod 1 na 10 bolesnika) su glavobolja, mijalgija (mišićna bol), bol i osjetljivost na mjestu injekcije te umor.
The most common side effects with Jevtana (seen in more than 1 patient in 10) include anaemia (low red blood cell counts), leucopenia (low white blood cell counts), neutropenia (low counts of neutrophils, a type of white blood cell), thrombocytopenia (low blood platelet counts) and diarrhoea.
Najčešće nuspojave lijeka Jevtana (uočene kod 1 na 10 bolesnika) uključivale su anemiju (mali broj bijelih krvnih stanica), leukopeniju (mali broj bijelih krvnih stanica), neutropeniju (mali broj neutrofila, tipa bijelih krvnih stanica), trombocitopeniju (mali broj trombocita u krvi) i proljev.
The most common side effects with Jinarc (which may affect more than 2 in 10 people) are thirst, polyuria (increase in urine production), nocturia (need to pass urine at night) and pollakiuria (increased need to pass urine during the day).
Najčešće nuspojave lijeka Jinarc (uočene kod 2 na 10 osoba) su žeđ, poliurija (povećana proizvodnja mokraće), nokturija (potreba za mokrenjem tijekom noći) i polakiurija (povećana potreba za mokrenjem tijekom dana).
The most common side effects with Kalydeco seen in patients aged 6 years and above are headache (23.9%), sore throat (22.0%), upper respiratory tract infection (colds, 22.0%), nasal congestion (20.2%), abdominal (belly) pain (15.6%), nasopharyngitis (inflammation of the nose and throat, 14.7%), diarrhoea (12.8%), dizziness (9.2%), rash (12.8%), bacteria in sputum (12.8%) and an increase in certain liver enzymes (12.8%).
Najčešće nuspojave lijeka Kalydeco zabilježene u bolesnika u dobi od šest godina i starijih su glavobolja (23,9 %), upala grla (22,0 %), infekcija gornjih dišnih puteva (prehlade, 22,0 %), začepljen nos (20,2 %), abdominalna bol (bolovi u trbuhu) (15,6 %), nazofaringitis (upala nosa i ždrijela, 14,7 %), proljev (12,8 %), vrtoglavica (9,2 %), osip (12,8 %), bakterije u ispljuvku (12,8 %) i povećanje određenih jetrenih enzima (12,8 %).
The most common side effects with Keytruda (which may affect more than 1 in 10 people) are diarrhoea, nausea (feeling sick), itching, rash, joint pain and tiredness, most of which are mild to moderate in severity.
Najčešće nuspojave lijeka Keytruda (mogu se pojaviti u više od 1 na 10 bolesnika) su proljev, mučnina (osjećaj slabosti), pruritus (svrbež), osip, bol u zglobovima i iscrpljenost (umor), od kojih je većina blaga do umjerena.
The most common side effects with Kineret (seen in more than 1 patient in 10) are headache, injection site reactions (redness, bruising, pain and inflammation), and increase in blood cholesterol.
Najčešće nuspojave lijeka Kineret (koje se mogu javiti u više od 1 na 10 osoba) su glavobolja i reakcije na mjestu injekcije (crvenilo, kontuzija, bol i upala) te povišenje kolesterola u krvi.
The most common side effects with Kiovig (seen in more than 1 patient in 10) are headache, hypertension (high blood pressure), nausea (feeling sick), rash, tiredness, local reactions such as pain, swelling or itching at the site of injection and pyrexia (fever).
Najčešće su nuspojave lijeka Kiovig (kod više od 1 na 10 osoba) glavobolja, hipertenzija (visoki krvni tlak), mučnina (osjećaj slabosti), osip, umor, lokalne reakcije poput boli, oticanja ili svrbeži na mjestu davanja injekcije te pireksija (groznica).
The most common side effects with Kuvan (seen in more than 1 patient in 10) are headache and rhinorrhoea (runny nose).
Najčešće nuspojave lijeka Kuvan (koje se mogu javiti u više od 1 na 10 osoba) su glavobolja i rinoroeja (curenje iscjetka iz nosa).
The most common side effects with Kyprolis (which may affect more than 1 in 5 people) are anaemia (low red blood cell counts), tiredness, diarrhoea, thrombocytopenia (low blood platelet counts), nausea (feeling sick), fever, dyspnoea (difficulty breathing), respiratory tract (airways) infection, cough and peripheral oedema (swelling, especially of the ankles and feet).
Najčešće nuspojave lijeka Kyprolis (mogu se javiti u više od 1 na 5 osoba) su anemija (niska razina crvenih krvnih stanica), umor, proljev, trombocitopenija (niska razina trombocita), mučnina, vrućica, dispneja (otežano disanje), infekcije dišnog sustava, kašalj i periferni edem (oticanje, osobito gležnjeva i stopala).
The most common side effects with Lartruvo (which may affect more than 1 in 10 people) include nausea (feeling sick), musculoskeletal pain (bone and muscle pain), neutropenia (low levels of neutrophils, a type of white blood cells that fights infection) and mucositis (inflammation of the body’s moist surfaces, most commonly affecting the mouth and throat).
Najčešće nuspojave lijeka Lartruvo (koje se mogu javiti u više od 1 na 10 osoba) uključuju mučninu, mišićno-koštanu bol (bol u kostima i mišićima), neutropeniju (niske razine neutrofila, vrste bijelih krvnih stanica koje suzbijaju infekciju) i mukozitis (upala vlažnih površina tijela, najčešće zahvaćaju usta i grlo).
The most common side effects with Leflunomide Winthrop (seen in between 1 and 10 patients in 100) are leucopenia (low white blood cell counts), mild allergic reactions, increased creatine phosphokinase levels (a marker of muscle damage), paraesthesia (abnormal sensations like pins and needles), peripheral neuropathy (nerve damage in hands and feet), headache, dizziness, mild increases in blood pressure, diarrhoea, nausea (feeling sick), vomiting, inflammation of the mouth such as mouth ulcers, abdominal pain (stomach ache), increased liver enzyme levels, hair loss, eczema, rash, pruritus (itching), dry skin, tenosynovitis (inflammation of the sheath surrounding the tendons), loss of appetite, weight loss and asthenia (weakness).
Najčešće nuspojave lijeka Leflunomide Winthrop (mogu se javiti u 1 do 10 bolesnika na 100) su leukopenija (mali broj bijelih krvnih stanica), blaga alergijska reakcija, povišene razine kreatin fosfokinaze (marker mišićnog oštećenja), parestezija (abnormalni osjeti poput ubadanja iglica), periferna neuropatija (oštećenje živca u dlanovima i stopalima), glavobolja, omaglica, blago povišeni krvni tlak, proljev, mučnina (osjećaj slabosti), povraćanje, upale usta poput usnih ulcera, abdominalna bol (trbuhobolja), povišeni jetreni enzimi, gubitak kose, ekcemi, osip, pruritus (svrbež), suha koža, tendozinovitis (upala ovojnice oko tetiva), gubitak apetita, gubitak tjelesne mase i astenija (slabost).
The most common side effects with Lenvima (which may affect more than 3 in 10 people) are hypertension (high blood pressure), diarrhoea, decreased appetite and weight, fatigue (tiredness), nausea (feeling sick), proteinuria (protein in the urine), stomatitis (inflammation of the lining of the mouth), vomiting, dysphonia (speech disturbances), headache and palmar-plantar erythrodysaesthesia syndrome (PPE - rash and numbness on the palms and soles).
Najčešće nuspojave lijeka Lenvima (uočene kod 3 na 10 osoba) su hipertenzija (visoki krvi tlak), proljev, smanjeni apetit i težina, iscrpljenost (umor), mučnina (osjećaj slabosti), proteinuirija (bjelančevine u mokraći), stomatitis (upala ovojnice usne šupljine), povraćanje, disfonija (poremećaj u govoru), glavobolja i palarno-plantaran sindrom eritrodisastezije (PPE - osip i utrnuće dlanova i tabana).
The most common side effects with Lixiana (which may affect up to 1 in 10 people) are bleeding from skin and soft tissues, nose bleeds (epistaxis) and the vagina.
Najčešće nuspojave lijeka Lixiana (koje se mogu javiti u manje od 1 na 10 osoba) su krvarenje iz kože i mekog tkiva, nosno krvarenje (epistaksa) te vaginalno krvarenje.
The most common side effects with Lonquex (which may affect more than 1 in 10 patients) are bone and muscle pain, which are generally mild to moderate in severity and can be treated with standard painkillers.
Najčešće nuspojave lijeka Lonquex (koje se mogu javiti u više od 1 na 10 osoba) su bolovi u kostima i mišićima, koji su obično blage do umjerene jačine i mogu se liječiti standardnim lijekovima protiv bolova.
The most common side effects with Lonsurf (which may affect more than 3 in 10 people) are neutropenia (low levels of neutrophils, a type of white blood cell that fights infection), nausea, tiredness, anaemia (low red blood cell counts) and leucopenia (low white blood cell counts).
Najčešće nuspojave lijeka Lonsurf (mogu se javiti u više od 3 na 10 osoba) su neutropenija (niske razine neutrofila, vrste bijelih krvnih stanica koje se bore protiv infekcija), mučnina, umor, anemija (niska razina crvenih krvnih stanica) i leukopenija (niska razina bijelih krvnih stanica).
The most common side effects with Lucentis (seen in more than 1 in 10 patients) are increased intraocular pressure (pressure within the eye), headache, vitritis (inflammation in the eye), vitreous detachment (separation of the vitreous from the back of the eye), retinal haemorrhage (bleeding at the back of the eye), visual disturbance, eye pain, vitreous floaters (spots in the vision), conjunctival haemorrhage (bleeding at the front of the eye), eye irritation, sensation of a foreign body in the eye, increased lacrimation (tear production), blepharitis (inflammation of the eyelids), dry eye, ocular hyperaemia (red eye), eye pruritis (itching), arthralgia (joint pain) and nasopharyngitis (inflammation of the nose and throat).
Najčešće nuspojave lijeka Lucentis (uočene u više od 1 na 10 bolesnika) su povišeni intraokularni tlak (tlak unutar oka), glavobolja, vitritis (upala oka), ablacija staklovine (odvajanje staklovine sa stražnje strane oka), krvarenje mrežnice (krvarenje stražnje strane oka), smetnje vida, bol u oku, opaciteti u staklovini (mrlje u vidu), krvarenje konjunktive (krvarenje u prednjem dijelu oka), iritacija oka, osjećaj stranog tijela u oku, pojačana lakrimacija (stvaranje suza), blefaritis (upala očnih kapaka), suho oko, okularna hiperemija (crveno oko), očni pruritus (svrbež), artralgija (bol u zglobu) i nazofaringitis (upala nosa i grla).
The most common side effects with Lynparza (which may affect more than 1 in 10 people) are fatigue (tiredness), nausea (feeling sick), vomiting, diarrhoea, dyspepsia (heartburn), headache, dysgeusia (taste disturbances), decreased appetite, dizziness, anaemia (low red blood cell counts), lymphopenia and neutropenia (low counts of certain types of white blood cell), mean corpuscular volume elevation (increase in the average size of red blood cells) and increase in creatinine (high levels of creatinine in blood indicates problems with kidney function).
Najčešće nuspojave Lynparza (mogu se javiti u više od 1 na 10 osoba) su iscrpljenost (umor), mučnina (osjećaj slabosti), povraćanje, proljev, dispepsija (žgaravica), glavobolja, disgeusija (poremećaj okusa), povećanje apetita, vrtoglavica, anemija (mali broj crvenih krvnih stanica), limfopenija i neutropenija (mali broj određenog tipa bijelih krvnih stanica), povećanje prosječnog volumena eritrocita (povećanje u prosječnoj veličini crvenih krvnih stanica) i povećanje u kreatininu (visoke razine kreatinina u krvi ukazuju na probleme u funkciji bubrega).
The most common side effects with M-M-RVAXPRO (seen in more than 1 patient in 10) are fever (38.5°C or higher), and injection site redness, pain and swelling.
Najčešće nuspojave s lijekom M-M-RVAXPRO (uočene kod više od 1 na 10 bolesnika) bile su vrućica (38,5 °C ili više) i crvenilo na mjestu injekcije, bol i oticanje.
The most common side effects with Mabthera intravenous infusions are reactions related to the infusion (such as fever, chills and shivering) while most common serious side effects are infusion reactions, infections and heart-related problems.
Najčešće su nuspojave uočene kod intravenskih infuzija lijeka MabThera reakcije povezane s infuzijom (kao što su vrućica, trnci i drhtavica), a najčešće su teške nuspojave reakcije na infuziju, infekcije i problemi sa srcem.
The most common side effects with Mekinist (which may affect more than 1 in 5 people) are rash, diarrhoea, fatigue, peripheral oedema (swelling, especially of ankles and feet), nausea and dermatitis acneiform (acne-like inflammation of the skin).
Najčešće nuspojave lijeka Mekinist (koje se mogu pojaviti kod više od 1 na 5 osoba) su osip, proljev, umor, periferni edem (oticanje, posebice gležnjeva i stopala), mučnina i akneiformni dermatitis (upala kože u obliku akni).
The most common side effects with methylthioninium chloride are nausea (feeling sick), abdominal and chest pain, headache, dizziness, tremors, anxiety, confusional state, dyspnoea (difficulty breathing), tachycardia (rapid heartbeat), hypertension (high blood pressure), hyperhidrosis (excessive sweating), pain at the site of injection or in a limb, and the formation of methaemoglobinaemia.
Najčešće nuspojave povezane s metiltioninijevim kloridom su mučnina (osjećaj slabosti), abdominalna bol i bol u prsima, glavobolja, vrtoglavica, tremori, anksioznost, konfuzija, dispneja (otežano disanje), tahikardija (ubrzani rad srca), hipertenzija (visoki krvni tlak), hiperhidroza (prekomjerno znojenje), bol na mjestu davanja injekcije ili u udu te formiranje methemoglobinemije.
The most common side effects with Nimenrix given a s a single injection (seen in more than 1 patient in 10) are loss of appetite, irritability, drowsiness, headache, fever, swelling, pain and redness at the site of injection, and tiredness.
Najčešće nuspojave cjepiva Nimenrix kad je davan kao jedna injekcija (zabilježene u više od 1 na 10 bolesnika) su gubitak teka, razdražljivost, pospanost, glavobolja, vrućica, oticanje, bol i crvenilo na mjestu injiciranja te umor.
The most common side effects with Nivolumab BMS (which may affect more than 1 in 10 people) are tiredness, decreased appetite, and nausea (feeling sick), which are mostly mild or moderate in severity.
Najčešće nuspojave lijeka Nivolumab BMS (mogu se javiti u više od 1 na 10 osoba) su iscrpljenost, smanjeni apetit i mučnina (osjećaj slabosti), a većina kojih je bila blaga do umjerena u svojoj ozbiljnosti.
The most common side effects with NovoEight (which may affect up to 1 in 10 people) are increased levels of liver enzymes and injection site reactions.
Najčešće nuspojave lijeka NovoEight (koje se mogu javiti u više od 1 na 10 osoba) su povišene razine enzima jetre i reakcije u mjestu injekcije.
The most common side effects with NovoThirteen (seen in between 1 and 10 patients in 100) are headache, leucopenia (low white blood cell counts), aggravated neutropenia (low levels of neutrophils, a type of white blood cell), pain in the extremities, injection site pain, and the presence in the blood of antibodies that attach to factor XIII and of small protein fragments called ‘fibrin D-dimer’.
Najčešće nuspojave lijeka NovoThirteen (kod između 1 i 10 osoba) su glavobolja, leukopenija (mali broj bijelih krvnih stanica), pogoršana neutropenija (niska razina neutrofila, tipa bijelih krvnih stanica), bol u ekstremitetima, bol na mjestu injekcije i prisutnost protutijela koja se vežu na faktor XIII i malog broja fragmenata proteina u krvi naziva „fibrinski D-dimeri”.
The most common side effects with Nplate (seen in more than 1 patient in 10) are headache and hypersensitivity (allergic reactions).
Najčešće nuspojave lijeka Nplate (mogu se javiti u više od 1 na 10 osoba) jesu glavobolja i preosjetljivost (alergijske reakcije).
The most common side effects with Oncaspar (which may affect more than 1 in 10 people) are allergic reactions (including serious allergic reactions), hives, rash, high blood sugar levels, pancreatitis (inflammation of the pancreas), diarrhoea, and abdominal (belly) pain.
Najčešće nuspojave pri primjeni lijeka Oncaspar (mogu se javiti u više od 1 na 10 osoba) su alergijske reakcije (uključujući teške alergijske reakcije), osip, svrabež, visoke razine šećera u krvi, pankreatitis (upala gušterače), proljev i abdominalna (trbušna) bol.
The most common side effects with Onivyde (which may affect more than 1 in 5 people) are diarrhoea, nausea (feeling sick), vomiting, loss of appetite, neutropenia (low levels of neutrophils, a type of white blood cell), tiredness, weakness, anaemia (low red blood cell counts) stomatitis (inflammation of the lining of the mouth) and fever.
Najčešće nuspojave lijeka Onivyde (koje se mogu javiti u više od 1 na 5 osoba) su proljev, mučnina (osjećaj slabosti), povraćanje, gubitak apetita, neutropenija (niska razina neutrofila, vrste bijelih krvnih stanica), umor, slabost, anemija (niska razina crvenih krvnih stanica), stomatitis (upala usne šupljine) i vrućica.
The most common side effects with Opdivo (which may affect more than 1 in 10 people) are tiredness, diarrhoea, nausea (feeling sick), rash and pruritus (itching), and decreased appetite, most of which are mild to moderate in severity.
Najčešće nuspojave lijeka Opdivo (koje se mogu javiti u više od 1 na 10 bolesnika) su umor, proljev, mučnina (povraćanje), osip i pruritus (svrbež) te smanjeni apetit, a većina ih je blaga do umjerena.
The most common side effects with Opsumit (which may affect more than 1 in 10 people) are nasopharyngitis (inflammation of the nose and throat), bronchitis (inflammation of the airways in the lungs), anaemia (low red blood cell counts) and headache.
Najčešće nuspojave od lijeka Opsumit (kod više od 1 na 10 osoba) su nazofaringitis (upala nosa i grla), bronhitis (upala zračnih putova u plućima), anemija (mali broj crvenih krvnih stanica) i glavobolja.
The most common side effects with Optimark (seen in between 1 and 10 patients in 100) are headache, dysgeusia (taste disturbances) and feeling hot.
Najčešće su nuspojave lijeka Optimark (zabilježene u između 1 i 10 na 100 bolesnika) glavobolja, dizguezija (poremećaj okusa) i osjećaj vrućine.